Sustained virological response rates with direct‐acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials

Under representation of black subjects in trials of hepatitis C virus (HCV) direct-acting antivirals (DAAs) complicates assessment of differential outcomes for black individuals non-black individuals. HCV trials submitted to the Food and Drug Administration (2013-2017) to support approval or to expa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Virus Eradication Jg. 5; H. 3; S. 138 - 144
Hauptverfasser:	Struble, Kimberly, Chan-Tack, Kirk, Qi, Karen, Valappil, Thamban, Connelly, Sarah, Mishra, Poonam, Price, Dionne, Murray, Jeffrey, Birnkrant, Debra
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Mediscript Ltd 18.09.2019 Elsevier
Schlagworte:	clinical trial Food and Drug Administration hepatitis C Original Research clinical trial hepatitis C Food and Drug Administration
ISSN:	2055-6640, 2055-6659
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!